152 related articles for article (PubMed ID: 11416967)
1. Macroprolactinaemia, the major unknown in the differential diagnosis of hyperprolactinaemia.
Cattaneo F; Kappeler D; Müller B
Swiss Med Wkly; 2001 Mar; 131(9-10):122-6. PubMed ID: 11416967
[TBL] [Abstract][Full Text] [Related]
2. Screening for macroprolactinaemia and pituitary imaging studies.
Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
[TBL] [Abstract][Full Text] [Related]
3. Patients with macroprolactinaemia: clinical and radiological features.
Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
[TBL] [Abstract][Full Text] [Related]
4. Interference by macroprolactin in assays for prolactin: will the
Fahie-Wilson MN; Cobbaert CM; Horvath AR; Smith TP
Clin Chem Lab Med; 2022 Aug; 60(9):1350-1355. PubMed ID: 35704648
[TBL] [Abstract][Full Text] [Related]
5. [Macroprolactinaemia].
Kostrzak A; Meczekalski B
Pol Merkur Lekarski; 2010 Jul; 29(169):47-9. PubMed ID: 20712249
[TBL] [Abstract][Full Text] [Related]
6. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.
Olukoga AO; Kane JW
Clin Endocrinol (Oxf); 1999 Jul; 51(1):119-26. PubMed ID: 10468974
[TBL] [Abstract][Full Text] [Related]
7. Macroprolactin screening in 464 patients with hyperprolactinaemia.
Lim MH; Ho CKM
Malays J Pathol; 2022 Aug; 44(2):261-267. PubMed ID: 36043589
[TBL] [Abstract][Full Text] [Related]
8. Determination of prolactin: the macroprolactin problem.
Fahie-Wilson M; Smith TP
Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642
[TBL] [Abstract][Full Text] [Related]
9. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
Hattori N; Ishihara T; Saiki Y
Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
[TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
[TBL] [Abstract][Full Text] [Related]
11. Should macroprolactin be measured in all hyperprolactinaemic sera?
McKenna TJ
Clin Endocrinol (Oxf); 2009 Oct; 71(4):466-9. PubMed ID: 19320649
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation.
Beda-Maluga K; Pisarek H; Komorowski J; Swietoslawski J; Fuss-Chmielewska J; Winczyk K
J Physiol Pharmacol; 2014 Jun; 65(3):359-64. PubMed ID: 24930507
[TBL] [Abstract][Full Text] [Related]
13. Macroprolactin-a cause of pseudohyperprolactinaemia.
Yuen YP; Lai JP; Au KM; Chan AY; Mak TW
Hong Kong Med J; 2003 Apr; 9(2):119-21. PubMed ID: 12668823
[TBL] [Abstract][Full Text] [Related]
14. Clinical and radiological features of patients with macroprolactinaemia.
Strachan MW; Teoh WL; Don-Wauchope AC; Seth J; Stoddart M; Beckett GJ
Clin Endocrinol (Oxf); 2003 Sep; 59(3):339-46. PubMed ID: 12919157
[TBL] [Abstract][Full Text] [Related]
15. The detection of macroprolactin by precipitation and ultrafiltration methods.
Beda-Maluga K; Pisarek H; Komorowski J; Pawlikowski M; Świętosławski J; Winczyk K
Endokrynol Pol; 2011; 62(6):529-36. PubMed ID: 22144220
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas.
Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A
Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748
[TBL] [Abstract][Full Text] [Related]
17. Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up.
Hattori N; Ishihara T; Saiki Y; Shimatsu A
Clin Endocrinol (Oxf); 2010 Dec; 73(6):792-7. PubMed ID: 20874771
[TBL] [Abstract][Full Text] [Related]
18. Importance of cannulated prolactin test in the definition of hyperprolactinaemia.
Whyte MB; Pramodh S; Srikugan L; Gilbert JA; Miell JP; Sherwood RA; McGregor AM; Aylwin SJ
Pituitary; 2015 Jun; 18(3):319-25. PubMed ID: 24879500
[TBL] [Abstract][Full Text] [Related]
19. Reference ranges for serum total and monomeric prolactin for the current generation Abbott Architect assay.
Whitehead SJ; Cornes MP; Ford C; Gama R
Ann Clin Biochem; 2015 Jan; 52(Pt 1):61-6. PubMed ID: 25074991
[TBL] [Abstract][Full Text] [Related]
20. Macroprolactin; high molecular mass forms of circulating prolactin.
Fahie-Wilson MN; John R; Ellis AR
Ann Clin Biochem; 2005 May; 42(Pt 3):175-92. PubMed ID: 15949152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]